Skip to content
Disclosery

Crossingbridge Advisors, LLC: NOEM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Crossingbridge Advisors, LLC on NOEM, newest first. How the timeline and the estimate are built.

Crossingbridge Advisors, LLC held 1,241 NOEM shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,241 shares
    Change vs previous 13F +1,241 shares

    <0.01% of the 13F portfolio, value $12,956.

    13F-HR 0001104659-26-095580 filed by Crossingbridge Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -25,000 shares

    13F-HR 0001104659-25-110900 filed by Crossingbridge Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  3. period ended2025-06-30
    13F 25,000 shares
    Change vs previous 13F -255,000 shares

    0.22% of the 13F portfolio, value $251,750.

    13F-HR 0001104659-25-077288 filed by Crossingbridge Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 280,000 shares
    Change vs previous 13F not available

    1.46% of the 13F portfolio, value $2,777,600.

    13F-HR 0001104659-25-048296 filed by Crossingbridge Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).